The University of Southern California (USC) Norris Comprehensive Cancer Center, Keck Medicine of USC, and the Keck School of Medicine of USC announced a $5 million gift from the Rosalie and Harold Rae Brown Charitable Foundation. The gift was received from Harold R. Brown, trustee of the foundation, to create and support the Rosalie and Harold Rae Brown Center for Cancer Drug Discovery within the USC Norris Comprehensive Cancer Center. The new center, named in honor of Mr. Brown’s parents, will focus on accelerating the development of groundbreaking cancer treatments.
Caryn Lerman, PhD
“The importance of conducting research to develop more effective and less toxic cancer therapies cannot be overestimated,” said Caryn Lerman, PhD, Director of the USC Norris Comprehensive Cancer Center and Associate Dean for Cancer Programs at the Keck School. “This gift will enable us to leverage the talent of USC Norris scientists and dedicated clinicians and ensure that our groundbreaking discoveries move not from bench to bookshelf, but from bench to bedside, transforming cancer care and survivorship for all people.”
Generosity of an Alumnus
Mr. Brown, who celebrates his 90th birthday in August, is a previous donor to USC Norris and graduated from USC with a Bachelor of Science degree in 1959. “I have been fortunate to do well in business, and now through my efforts as trustee of the Rosalie and Harold Rae Brown Charitable Foundation, want to give back to a cause that is not only personally important to me, but addresses a great need in society, finding a cure for cancer,” he remarked. “Honoring my parents and creating the Rosalie and Harold Rae Brown Center for Cancer Drug Discovery at USC Norris is a rewarding and fitting legacy.”
This gift will have an immediate impact by supporting the development of new clinical trials that build on USC Norris discoveries of the underlying causes of cancer and disease progression. Initial projects will be sharply focused on cancers that disproportionately affect members of the community for whom there are dramatic ethnic and racial disparities, such as breast, prostate, and colorectal cancers.